For Admin
A Leading Company in Nasal Drug Delivery
SNBL’s nasal drug delivery platform is a proprietary system consisting of powder carrier technology and delivery device technology.
3D Nasal Cast Model
November 24, 2022
SNBL’s Comments on Results from Clinical Phase 3 Studies of STS101, an Investigational Migraine Drug Candidate, Announced by Satsuma Pharmaceuticals, Inc.
November 14, 2022
Satsuma Pharmaceuticals Announces Topline Results from the STS101 SUMMIT Phase 3 Efficacy Trial for the Acute Treatment of Migraine
September 21, 2022
Satsuma Pharmaceuticals Announces Positive Results from the Ongoing STS101 ASCEND Phase 3 Open-label, Long-term Safety Trial
2024|2023|2022|2021|2020|2019|2018|2016|2015|2014|2013|2012〜